TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: mean outbreak duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month postoperative stone-free rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak GH values after GHRH administration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: GH release after GHRP-6 injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: duration of absence from work
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Larger gray matter volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Average injection time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain and distress reaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Prevalence of age-specific and sex-specific refractive error
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: daily milk yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage of continuous hip capsules seen on MRI at 6 weeks postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Inhibition of endothelium dependent vasorelaxation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Triglyceride over-enrichment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Incidence of fractures
Endpoint domain: Mortality/survival
Primary endpoint: complete remission rate
Endpoint domain: Mortality/survival
Primary endpoint: treatment effects in OA patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: gastrointestinal safety profile
Endpoint domain: Adverse events/effects
Primary endpoint: Tdap vaccination rate during the perinatal period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: PST measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: IR measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Patient mobilisation time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for intravenous fluids
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: T95% variability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: postoperative first analgesic requirement times
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pain satisfaction scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: evoked pain intensity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of morbidity (cerebral infarction and reversible ischemic neurological deficits)
Endpoint domain: Mortality/survival
Primary endpoint: pain and analgesic requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: delirious awakening
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: trouble sleeping
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Malignancies reported
Endpoint domain: Mortality/survival
Primary endpoint: Deaths reported
Endpoint domain: Mortality/survival
Primary endpoint: Patient satisfaction with treatment result
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Secretion of IFN-gamma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Secretion of IL-4
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mortality rate at 30 days
Endpoint domain: Mortality/survival
Primary endpoint: rates of death/MI
Endpoint domain: Adverse events/effects
Primary endpoint: rates of bleeding complications
Endpoint domain: Adverse events/effects
Primary endpoint: Time before catheter failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Persistent postoperative neurologic dysfunction at 1 month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: TNF receptor 1 (TNFR1) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: matrix metalloproteinase 7 (MMP7) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fibronectin 1 (FN1) plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean bleeding rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cerebral desaturation
Endpoint domain: Adverse events/effects
Primary endpoint: LVEF measurements below 50%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: NT-proBNP levels below 400 pg/ml
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in postprandial glucagon excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Reduction in postprandial glucose excursions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Slowed gastric emptying
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Percentage of CD(4)(+) and CD(8)(+) T cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: STC summary score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: High Hcy levels predicting AT events
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean change in total UPDRS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of root position assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of root number assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient preference for sodium phosphate preparation
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Effectiveness in colonic cleansing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Incidence of hyperphosphatemia
Endpoint domain: Adverse events/effects
Primary endpoint: EASI-75 response maintenance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SIA of the anterior surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SIA of the posterior surface
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Median satisfaction with sedation
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Maximal power output (Wmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endurance duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dyspnea score (Borg CR10 Scale)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Change in systolic BP at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: percentage of subjective improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Erection quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration of vibratory stimulation (ELT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of graft occlusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Serotype-specific IgG geometric mean concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: fiber intake improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost-effectiveness of video method
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: HIV acquisition
Endpoint domain: Mortality/survival
Primary endpoint: HIV transmission
Endpoint domain: Mortality/survival
Primary endpoint: Physical functioning improvements
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: tooth-brushing duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: SEE scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: OEES scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: BAL inflammatory cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Subepithelial reticular basement membrane thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Discharge as a day case
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: SGRQ scores improvement
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: intake frequency of healthy foods (meat, vegetables, fruits)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intake frequency of unhealthy foods (sweet drinks, ice cream)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AWV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Desire to drink
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of drinks consumed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ocular pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood sugar level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in SF-36P score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Psychosis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients experiencing hypoglycaemia episodes
Endpoint domain: Adverse events/effects
Primary endpoint: Median time to failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time taken per question
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean discrimination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Septic complication rates
Endpoint domain: Adverse events/effects
Primary endpoint: decline in traumatic stress symptoms
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: decline in total mood disturbance
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean daily OFF-time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MDS-UPDRS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's Disease Questionnaire-39 Summary Index Score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of life (SF-36 scores)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: urine leak complication
Endpoint domain: Adverse events/effects
Primary endpoint: Mimic disturbances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: annualized asthma exacerbation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: prebronchodilator forced expiratory volume in 1 second
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of diabetic retinopathy screening examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Diabetic retinopathy worsening by 2 stages or more
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: range of knee motion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Central corneal edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal steepening
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Myopic shift in refraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: management of everyday life
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: health care consumption
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: H. pylori eradication at 1 month posttreatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Microvascular flow index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Perfused vessel density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total vascular density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in AD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity Scoring of Atopic Dermatitis (SCORAD) index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: adverse reaction incidence
Endpoint domain: Adverse events/effects
Primary endpoint: symptom and sign disappeared time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative 48-h FCA of EC calcium
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Serum DHEAS levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: fallopian tube patency rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Incidence of Modic changes (MC)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of patients with >50% clearance of melasma and solar lentigo
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recurrence rates of melasma and solar lentigo
Endpoint domain: Adverse events/effects
Primary endpoint: Completion rates of AIMS records vs handwritten records
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in total cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: changes in triglycerides
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: changes in insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Dose conversion ratio between epoetin alfa and darbepoetin alfa
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Role functioning (emotional)
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Contraction volume of the first smooth-muscle segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total contraction volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Amplitude of the trough separating smooth-muscle segments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in blood glucose control (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of platelet serotonin transporters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: investigator-observed flushing as a predictor of ALDH2 genotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Donor-site pain scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Cure rates on Day 14
Endpoint domain: Mortality/survival
Primary endpoint: lives saved
Endpoint domain: Mortality/survival
Primary endpoint: Transit time through lower digestive tracts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Transit time through whole gut
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: True streptococcal infections
Endpoint domain: Adverse events/effects
Primary endpoint: RF recurrences
Endpoint domain: Adverse events/effects
Primary endpoint: Prophylaxis failure
Endpoint domain: Adverse events/effects
Primary endpoint: improvement in insomnia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to suicidal ideation or attempt
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in PPD [mm]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of residual BOP positive teeth [%]
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Berg balance scale scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mediolateral oscillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to first occurrence of new atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: symptom responses to artificial interferences
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cumulative implant failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Average marginal bone level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-h plasma glucose area response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 24-h integrated serum insulin area response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement in right upper limb functions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: increase in minutes of physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remission of female sexual dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: remaining sexually active
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: improvement in total FSFI scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: area under the concentration curve (AUC0‐24)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean residence time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life improvement (FACIT-F)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Strength of upper and lower limbs improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of grade I‐IV elevation of serum transaminase and/or bilirubin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Incidence of grade II‐IV hepatic injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Mean working time for placement and removal of eyelet wiring
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Mean plaque index values
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidences of glove perforation, soft tissue trauma, and trauma to the operator's finger
Endpoint domain: Adverse events/effects
Primary endpoint: Difficulty of maneuvering
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: RMDQ scores
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: ischaemic CV events
Endpoint domain: Mortality/survival
Primary endpoint: Mean fasting blood glucose (FBS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Microalbumin level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Serum hs-CRP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Return to walking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome on the Barthel Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional outcome on the Rivermead Motor Assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Uteroplacental vascular impedance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Withdrawal rates attributed to adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of vitreous loss
Endpoint domain: Adverse events/effects
Primary endpoint: patient preference for topical anesthesia
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: anesthesia-related intraoperative difficulty
Endpoint domain: Adverse events/effects
Primary endpoint: Hemoglobin levels among newborns after 12 hours
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Improvements in cognition (MMSE, MoCA, TMT-A, TMT-B)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Subfoveal choroidal thickness (SCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nasal choroidal thickness (NCT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes